Table 2. Demographic, clinical and titre information of four stratified groups.
adult+adlc | Child | qHPV vac | Remisn | |
---|---|---|---|---|
n = 36 Median (Range) | n = 16 Median (Range) | n = 8 Median (Range) | n = 10 Median (Range) | |
Age at Phlebotomy (Years) | 44 (14–84) | 4 (1–9) | 32 (11–65) | 38 (7–73) |
Age at Diagnosis (Years) | 31 (1–77) | 2 (0–5) | 15 (1–35) | 25 (1–69) |
Duration of Symptoms (Years) | 11 (1–69) | 3 (0–8) | 9 (3–58) | 9 (5–32) |
Time since last RRP surgery (Days) | 93 (14–768) | 57 (20–359) | 129 (4–1834) | 1050 (599–8160) |
Clinical Course (Aggressive vs Indolent) | 61% | 69% | 75% | 60% |
anti-HPV 6 titre (when positive) GMT with IQR | 88 (31–156) n = 16 | 137 (82–286) n = 3 | 400 (138–883) n = 8 | 51 (28–102) n = 3 |
anti-HPV11 titre (when positive) GMT with IQR | 98 (43–193) n = 7 | n = 0 | 446 (147–1588) n = 7 | 16 n = 1 |